Kristen A. Marrone, MD
Medical Oncology
- Johns Hopkins School of Medicine Faculty
About Kristen A. Marrone
Professional Titles
- Program Director, Hematology/Medical Oncology Fellowship Program
Primary Academic Title
Associate Professor of Oncology
Background
Dr. Kristen Marrone is a thoracic medical oncology specialist in Baltimore, caring for patients with lung cancer and esophageal cancer. She is the Program Director of the Hematology/Medical Oncology Fellowship Program at the Johns Hopkins School of Medicine.
Dr. Marrone received her undergraduate degree in psychology with a neuroscience concentration from Pennsylvania State University. She earned her M.D. from Drexel University College of Medicine. She completed her residency at Yale-New Haven Hospital and performed a fellowship in medical oncology at Johns Hopkins University School of Medicine. Dr. Marrone joined the Johns Hopkins faculty in 2017.
Her research interests include clinical trial development and translational studies focusing on optimization of immunotherapy in oncogene driven non-small cell lung cancer.
Dr. Marrone is a member of the American Association of Cancer Research, the American Society of Clinical Oncology, the International Association for Study of Lung Cancer and the Society for Immunotherapy in Cancer.
Centers and Institutes
Clinical Trial Keywords
Non-Small Cell Lung Cancer (NSCLC); epidermal derived growth factor receptor (EGFR); KRAS
Research Interests
Immunotherapy, Non-small Cell Lung Cancer (NSCLC), Oncogene Mutated NSCLC, Tumor Metabolism
Research Summary
Non-small cell lung cancer (NSCLC); oncogene mutated NSCLC; immunotherapy; tumor metabolism
Selected Publications
Balaji A, Zhang J, Wills B, Marrone KA, Elmariah H, Yarchoan M, Zimmerman JW, Hajjir K, Venkatraman D, Armstrong DK, Laheru DA, Mehra R, Ho WJ, Reuss JE, Heng J, Vellanki P, Donehower RC, Holdhoff M, Naidoo J. “Immune-Related Adverse Events Requiring Hospitalization: Spectrum of Toxicity, Treatment, and Outcomes.” J Oncol Pract. 2019 Sep;15(9):e825-e834
Cortazar FB, Kibbelaar ZA, Glezerman IG, Abudayyeh A, Mamlouk O, Motwani SS, Murakami N, Herrmann SM, Manohar S, Shirali AC, Kitchlu A, Shirazian S, Assal A, Vijayan A, Renaghan AD, Ortiz-Melo DI, Rangarajan S, Malik AB, Hogan JJ, Dinh AR, Shin DS, Marrone KA, Mithani Z, Johnson DB, Hosseini A, Uprety D, Sharma S, Gupta S, Reynolds KL, Sise ME, Leaf DE. “Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study.” J Am Soc Nephrol. 2020 Feb;31(2):435-446
Suresh K, Naidoo J, Zhong Q, Xiong Y, Mammen J, de Flores MV, Cappelli L, Balaji A, Palmer T, Forde PM, Anagnostou V, Ettinger DS, Marrone KA, Kelly RJ, Hann CL, Levy B, Feliciano JL, Lin CT, Feller-Kopman D, Lerner AD, Lee H, Shafiq M, Yarmus L, Lipson EJ, Soloski M, Brahmer JR, Danoff SK, D'Alessio F. “The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis.” J Clin Invest. 2019 Jul 16;130:4305-4315. Parikh AB, Marrone KA, Becker DJ, Brahmer JR, Ettinger DS, Levy BP. “A pooled analysis of two phase II trials evaluating metformin plus platinum-based chemotherapy in advanced non-small cell lung cancer.” Cancer Treat Res Commun. 2019 May 10;20: 100150
Topper MJ, Vaz M, Marrone KA, Brahmer JR, Baylin SB. “The emerging role of epigenetic therapeutics in immuno-oncology.” Nat Rev Clin Oncol. 2020 Feb;17(2):75-90
Zhang J, Ji Z, Caushi JX, El Asmar M, Anagnostou V, Cottrell TR, Chan HY, Suri P, Guo H, Merghoub T, Chaft JE, Reuss JE, Tam AJ, Blosser RL, Abu-Akeel M, Sidhom JW, Zhao N, Ha JS, Jones DR, Marrone KA, Naidoo J, Gabrielson E, Taube JM, Velculescu VE, Brahmer JR, Housseau F, Hellmann MD, Forde PM, Pardoll DM, Ji H, Smith KN. “Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non-Small Cell Lung Cancer.” Clin Cancer Res. 2019 Nov 21
Courses & Syllabi
- Mock Tumor Board, 1/1/18
- Epidemiology, Staging and Molecular Diagnosis in Cancer, 1/1/18
- Genes to Society Pulmonary Course, Student Presentations, 1/1/17
- Summer Lecture Series-Lung Cancer Case Review, 1/1/17
- Oncologic Emergencies, 1/1/16
- Genes to Society Oncology Course, 1/1/16
Honors
- Gold Humanism Honor Society, 1/1/13
- Alpha Omega Alpha, Member, 1/1/11
Graduate Program Affiliations
Oncology - Upper Aerodigestive Disease
Memberships
- American Association of Cancer Research
- American Society of Clinical Oncology (ASCO)
- International Association for the Study of Lung Cancer (IASLC)
- Society for Immunotherapy in Cancer
Locations
- Johns Hopkins Bayview Medical Center
- 300 Mason Lord Drive, Kimmel Cancer Center, Baltimore, MD 21224
- phone: 410-550-1711
- fax: 410-550-1116
Expertise
Education
Johns Hopkins University School of Medicine
Fellowship, Hematology and Oncology, 2017Yale New Haven Health
Residency, Internal Medicine, 2014Drexel University College of Medicine
Medical Education, MD, 2011Board Certifications
Medical Oncology
American Board of Internal Medicine, 2017Internal Medicine
American Board of Internal Medicine, 2014Insurance
- Aetna
- CareFirst
- Cigna
- First Health
- Geisinger Health Plan
- HealthSmart/Accel
- Humana
- Johns Hopkins Health Plans
- MultiPlan
- Pennsylvania's Preferred Health Networks (PPHN)
- Point Comfort Underwriters
- Private Healthcare Systems (PHCS)
- UnitedHealthcare
- Veteran Affairs Community Care Network (Optum-VACCN)
Ratings & Reviews
5 out of 5
37 ratings, 14 reviewsThe Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
- 5 out of 5 starsReviewed on 12/10/2024
They r the best makes u feel cared for
- 5 out of 5 starsReviewed on 11/26/2024
Excellent doctor who show kindness and listens
- 5 out of 5 starsReviewed on 10/30/2024
Excellent
- 5 out of 5 starsReviewed on 9/24/2024
Knowledgeable, compassionate, attentive
- 5 out of 5 starsReviewed on 9/10/2024
Great.Thank you.
- 5 out of 5 starsReviewed on 8/6/2024
Excellent doctor. So fortunate to have her working with me on my health care journey.
- 5 out of 5 starsReviewed on 8/6/2024
Very attuned to my situation and my questions
- 5 out of 5 starsReviewed on 7/16/2024
Excellent Dr.
- 5 out of 5 starsReviewed on 7/9/2024
Dr. Marrone is the best oncologist I am so thankful and grateful to her for all she has done. I love her from the bottom of my heart
- 5 out of 5 starsReviewed on 7/9/2024
Excellent, takes time to explain all
- 5 out of 5 starsReviewed on 5/28/2024
Awesome
- 5 out of 5 starsReviewed on 4/30/2024
Listens and is concerned. Was late for appointment but gives time and concern for all patients. I feel was probably late because she was providing the time needed to patient before me.
- 5 out of 5 starsReviewed on 3/12/2024
She is incredibly knowledgeable; open to my extensive questions, clarifies as needed, and is extremely empathetic regarding my concerns and situation.
- 5 out of 5 starsReviewed on 2/20/2024
Very top of her profession. Outstanding, caring physician.